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Bipolar disorder (BD) is a severe and lifelong condition. Primary endogenic polygenetic 
forms are common. Secondary organic forms have received increasing interest recently 
due to the detection of immunological encephalopathies that mimic various psychiatric 
syndromes, including BD. However, only limited data about routine findings of cerebro-
spinal fluid (CSF) analyses in BD are available. Therefore, we investigated the frequency 
of alterations in the CSF in patients with BD and the association with autoantibodies, 
cerebral magnetic resonance imaging, and electroencephalography findings. CSF sam-
ples of patients with BD collected from January 1998 until December 2015 were analyzed 
retrospectively. Patients with preexisting causes for alterations in the CSF (e.g., patients 
with obvious past or current neurological disorders) were excluded. In total, 63 patients 
with BD fulfilled the inclusion criteria for the study. In 1.6% of the patients with BD, an 
increased white blood cell count was found in the CSF. Increased albumin quotients 
were found in 12.9% of the patients, oligoclonal bands (OCBs) in 1.6%, and increased 
immunoglobulin (Ig) G indices in 3.2% (OCBs were not measured in case of increased 
IgG indices). No significant differences in CSF findings were found between patients with 
manic and depressive episodes. The main findings of this open uncontrolled study are 
that alterations in the CSF may be found in a small, but potentially relevant, subgroup 
of patients with BD. These findings are discussed in light of the new concepts of mild 
encephalitis and immunological encephalopathy. The detection of patients with possibly 
secondary organic bipolar syndromes could open up new causal treatment options with 
immunomodulatory medication.
Keywords: cerebrospinal fluid, bipolar disorder, blood–brain-barrier dysfunction, immunological encephalopathy, 
mild encephalitis
inTrODUcTiOn
Bipolar Disorder
Bipolar disorder (BD) is a severe, lifelong condition with prevalence rates of 1–4% (1, 2). The underlying 
pathophysiological mechanisms are not completely understood. Primary polygenetic forms might 
be common (3). However, secondary forms due to inflammatory processes have received increased 
interest in the last few decades since autoantibody-associated immunological encephalopathies that 
TaBle 1 | The bipolar disorder patient cohort.
available bipolar disorder csF cohort 
from 1998 until 2015
75
reasons for exclusion
Infectious encephalitis 2 (1× viral encephalitis,  
1× tick-borne encephalitis)
Demyelinating diseases 2 (2× multiple sclerosis)
Delirium 1 (most likely medication-induced)
Dementia 2 (1× Alzheimer’s disease,  
1× multifactorial dementia)
Brain tumor/brain surgery 1 (medulloblastoma)
Movement disorders 2 (1× Parkinson’s disease,  
1× unclear spastic tetraparesis)
Traumatic brain injury 1 (severe cerebral contusion)
Previous stroke 1 (repeated ischemic stroke)
Bipolar disorder cohort for analyses 63
2
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mimic various psychiatric syndromes were detected (4). In line 
with this, we earlier published several case reports about patients 
with autoantibody-associated immunological encephalopathies 
who presented with isolated depressive or schizophreniform 
syndromes (5–8). Other authors have also described bipolar 
syndromes associated with underlying immunological encepha-
lopathies [e.g., caused by thyroid autoantibodies (9–11)]. The 
idea of immunological dysfunction leading to mild encephalitis 
(12) is supported by epidemiological observations (i.e., increased 
rate of other autoimmune diseases in BD) and laboratory findings 
[e.g., circulating immune markers, inflammatory central nervous 
system (CNS) alterations (13)].
cerebrospinal Fluid analyses and earlier 
Findings in Bipolar Disorder
Cerebrospinal fluid (CSF) analysis is the most precise method for 
detecting CNS inflammation. In routine CSF analysis, the total 
white blood cell (WBC) count, total protein concentration, albu-
min quotient, intrathecal immunoglobulin synthesis (IgG/A/M), 
IgG index, oligoclonal bands (OCBs), and lactate concentration 
are measured (14). Reports of routine CSF findings in patients 
with BD are scarce and have limited sample size. Pazzaglia et al. 
described increased total protein concentration in 55% of male 
patients with BD compared to only 10.5% in female patients with 
BD (15). This gender-specific finding was confirmed in another 
study (16). However, increased total protein concentrations are 
an unspecific and imprecise marker for blood–brain barrier 
(BBB) function, which is assessed more precisely by the albumin 
quotient (14). BBB dysfunction might be due to antipsychotic 
treatment in patients with BD (17). Elevated lactate concentra-
tions are typically found in patients with purulent meningitis but 
also in patients with ischemic stroke and mitochondriopathies 
(14). Interestingly, Regenold et al. (18) also found increased lac-
tate concentrations in 5 out of 15 patients with BD. The research-
ers interpreted this finding as a consequence of mitochondrial 
dysfunction (18).
rationale of the study
There is relevant evidence that inflammatory processes might 
lead to secondary forms of BD. However, only limited data about 
CSF basic diagnostic findings in BD are available. The current 
retrospective study was performed within this context. The aim of 
this project was to investigate the frequency of alterations in the 
CSF in BD. It was hypothesized that alterations would be found 
in the WBC count and BBB function, as well as that intrathecal 
humoral immune response would be found in the CSF of bipolar 
patient subgroups as markers of immunological dysbalance. In 
addition, CSF findings for patients with manic and depressive 
episodes were compared in an exploratory manner to detect 
possible differences.
ParTiciPanTs anD MeThODs
The study was approved by the local ethics committee (Faculty of 
Medicine, Freiburg University, EK-Fr 609/14). All measurements 
were part of the routine clinical workup. All patients gave written 
informed consent for lumbar punctures and cerebral magnetic 
resonance imaging (cMRI) diagnostics.
csF samples
The CSF samples collected from January 1998 until December 
2015 were analyzed retrospectively. The information was 
extracted from our CSF database, which was established in previ-
ous projects (19, 20). Routine CSF results were available for 75 
patients with BD. Some of the patients were included in a previ-
ous research project (21). Comorbid somatic, neurological, and 
psychiatric diseases were obtained from medical reports. Patients 
with obvious past or current brain disorders, such as infectious 
encephalitis or meningitis, demyelinating diseases, stroke, brain 
tumors, epilepsy, delirium, dementia, traumatic brain disease, 
or earlier brain surgery were excluded as were hemolytic CSF 
samples. Headache due to migraine or tension headache and 
mild cognitive impairment were not exclusion criteria. Finally, 63 
patients with BD were included in the descriptive and statistical 
analyses (Tables 1 and 2).
Procedure of Basic Diagnostic analyses
Laboratory investigations were performed in the CSF labora-
tory of the Department of Neurology of the University Medical 
Center Freiburg.1 The immunological assessment methods were 
described in previous papers (19, 20). Briefly, CSF WBC count 
and cytological differentiation were performed with manual 
microscopy (Leica DMRB, Germany) using a Fuchs–Rosenthal 
counting chamber (Hecht-Assistant, Germany). The basic 
quantitative protein diagnostics included total CSF protein, 
albumin, and immunoglobulin G, M, and A concentrations 
in the CSF and serum (ProSpect System, Siemens, Erlangen, 
Germany). Paired CSF and serum samples collected on the 
same date were analyzed simultaneously. For detection of BBB 
dysfunction, age-related albumin quotients were calculated 
(22). Intrathecal immunoglobulin synthesis was considered 
significant if the intrathecal immunoglobulin fraction exceeded 
10% of the Reibergram (22), the IgG index was >0.7 mg/l, and/
1 www.uniklinik-freiburg.de/neurologie/klinik/diagnostische-einrichtungen/
liquor-labor.html.
TaBle 2 | available datasets.
Diagnostic measurements number of 
samples
CSF basic diagnostics (WBC count, protein concentration, 
albumin quotient, and intrathecal immunoglobulin synthesis)
63
Intracellular synaptic and onconeural antigens (GAD, 
amphiphysin, Yo, Hu, Ri, Cv2/CRMP5, Ma1, Ma2, and SOX1)
29
Antibodies against neuronal cell surface antigens (NMDAR, 
AMPA-1/2-R, GABA-B-R, and VGKC-complex: LGI1 and 
CASPR2)
23
Electroencephalography data sets 61
Magnetic resonance imaging data sets 50a
aFor eight patients, only cranial computer tomography was available.
WBC, white blood cell; GAD, glutamic acid decarboxylase; Yo/Hu/Ri, abbreviations of 
first patients’ name; Cv2/CRMP5, anti-collapsin response-mediator protein; Ma1/Ma2, 
37, and 40 kDa neuronal proteins; SOX1, sry-like high-mobility group box 1; NMDAR, 
N-methyl-d-aspartat-receptor; AMPA-1/2-R, α-amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid receptor; GABA-B-R, γ-aminobutyric acid receptor; VGKC-complex, 
voltage-gated potassium channels complex; LGI1, leucine-rich glioma-inactivated 1; 
CASPR2, contactin-associated protein-like 2.
TaBle 3 | csF basic diagnostics in bipolar patients.
csF measurement Mean ± sD number of cases Frequency of alterations Threshold
White blood cell count (n = 62) 1.35 ± 0.87 ↔: 61; ↑: 1 (cell count: 6/μl) 1.6% <5/μl
Total protein concentration (n = 60) 436.40 ± 218.93 ↔: 36; ↑: 24 40% <450 mg/l
Albumin quotient (n = 62) 5.97 ± 3.00 ↔: 54; ↑: 8 12.9% <40 years: 6.5 × 10−3; 40–60 years:  
8.0 × 10−3; >60 years: 9.3 × 10−3 (14)
Immunoglobulin-G-index (n = 63) 0.50 ± 0.13 ↔: 61; ↑: 2 3.2% Immunoglobulin-G-index ≤0.7 mg/l (14)
Oligoclonal bands (n = 61a) – No: 58; Yes: 3
 – OCB restricted to CSF: 1
 – OCB mirror pattern: 2
4.9%; OCB restricted to CSF: 
1.6%; OCB mirror pattern: 3.3%
No oligoclonal bands
CSF, cerebrospinal fluid; OCBs, oligoclonal bands; ↔, value within normal range; ↑, value above normal upper limit of normal.
aIn cases of increased IgG-Index, no oligoclonal bands were measured.
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or if the OCBs – measured using isoelectric focusing followed 
by immunofixation (Hydragel Isofocusing, Sebia, France) – were 
present exclusively or predominantly in the CSF (23). In cases of 
an increased IgG index, no OCBs were measured. To avoid false-
positive findings, we also described the albumin quotient and 
the immunoglobulin fraction of the Reibergram in these cases. 
Clear-cut alterations in the CSF were defined as increased WBC 
count, increased age-dependent albumin quotient, or intrathe-
cal immunoglobulin synthesis. Antineuronal antibodies against 
onconeural intracellular or synaptic antigens were analyzed using 
an immunoblot employing recombinant neuronal antigens as the 
substrate (ravo Diagnostika, Freiburg, Germany). CSF antibod-
ies against neuronal cell surface antigens were measured using 
a non-specific cell-based [transfected human embryonic kidney 
(HEK) cells] indirect immunofluorescence assay (Euroimmun, 
Luebeck, Germany). The cMRI images were evaluated by experi-
enced senior neuroradiologists, and the electroencephalograms 
(EEGs) were analyzed by in-house physicians.
statistical analysis
All laboratory and instrument-based diagnostic findings, as well 
as clinical information, were entered into a Statistical Package 
for the Social Sciences (SPSS) database. The main findings of 
alterations were presented descriptively in absolute values and 
percentage figures. For group comparisons (for the CSF findings) 
between manic and depressive patients, an independent-sample 
t-test for continuous variables was performed. For group com-
parisons (for alterations in cMRI and EEG) between patients 
with and without alterations in the CSF, a Pearson’s two-sided 
chi-square test was performed. A p value of less than 0.05 was 
considered statistically significant for the statistical analyses.
resUlTs
Demographic Data
The mean age of all patients was 48.35 ± 15.22 years. The gender 
ratio in the study was 25 men to 38 women. At the time of the 
lumbar puncture, the patient group comprised 18 patients with 
manic episodes, 35 with depressive episodes, and 7 with mixed 
episodes. In three patients, lumbar puncture was performed after 
recovery or remission of an acute manic or depressive episode; 
in all other patients, lumbar puncture was performed while the 
patients were symptomatic.
routine csF Diagnostics
In the BD group, 1.6% showed an increased WBC count. A 
false-positive pleocytosis due to hemolytic CSF was excluded. 
In 40% of the samples, an increased total protein concentration 
and, in 12.9%, an increased albumin quotient was found. OCBs 
were detected in 1.6% and increased immunoglobulin (Ig) G 
indices in 3.2% (OCBs were not measured in case of increased 
IgG indices). The CSF findings are summarized in Table 3. The 
characteristics of the patients with CSF alterations are presented 
in Table 4. In Patient 3, the increased IgG index was in line with 
a normal albumin quotient and a relevant IgG fraction in the 
Reibergram (~50%). In Patient 4 (Table  4), the increased IgG 
index was found in combination with a normal albumin quotient 
and a borderline IgG fraction in the Reibergram (~10%). In sum-
mary, the basic CSF diagnostic findings showed alterations in 28 
of the 63 patients with BD (44.4%). Apart from the increased total 
protein concentration, clear-cut alterations were found in 12 of 63 
patients (19%). None of the patients with clear-cut CSF patholo-
gies had combined alterations in WBC count, albumin quotient, 
and intrathecal immunoglobulin synthesis. No autoantibodies 
against intracellular antigens or neuronal cell surface antigens 
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TaBle 5 | cMri and eeg pathologies in patients with bipolar syndromes.
localization of cMri alterationsa Frequency absoluteb (%)
White matter lesions/cerebral microangiopathy 22/50 (44)
Cortical atrophy 2/50 (4)
Postischemic changes 1/50 (2)
Other alterations 3/50 (6)
Cerebellar cavernoma 1/50 (2)
Mild asymmetrical hippocampi 1/50 (2)
Mild gliosis 1/50 (2)
Anatomic variations 2/50 (4)
Arteriovenous malformation 1/50 (2)
Aplasia of the left transverse sinus 1/50 (2)
Overall cMRI alterations 30/50 (60)
eeg pathologies Frequency absoluteb (%)
Continuous generalized slow activity 2/61 (3)
Continuous regional slow activity 0/61 (0)
Intermittent generalized slow activity 9/61 (15)
Intermittent regional slow activity 3/61 (5)
Epileptic activity 0/61 (0)
Overall EEG pathologies 14/61 (23)
aFor eight patients, only cranial computer tomography was available.
bOnly the predominant cMRI lesion or EEG alteration is listed for each patient.
cMRI, cerebral magnetic resonance imaging; EEG, electroencephalography.
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were found. Seven of the eight patients (87.5%) with increased 
albumin quotients were male. The EEG was abnormal in one of 
these eight patients (12.5%), and the cMRI showed pathologies in 
four out of six patients (66.7%).
cMri and eeg
In 60% of the patients, cMRI alterations were detected. In most 
cases, unspecific white matter lesions (44%) were detected. EEG 
abnormalities were found in 23% of the patients, the majority of 
which were intermittent generalized slow activities (IRDAs in 
15%; Table 5).
subgroup analyses
A comparison of the CSF findings in patients with manic (n = 18) 
and depressive symptoms (n = 35) showed no statistically signifi-
cant differences in the WBC count (1.24 ± 0.44 vs. 1.40 ± 1.06; 
p = 0.543, n = 52), total protein concentration (382.50 ± 172.99 vs. 
465.65 ± 255.47; p = 0.245, n = 50), albumin quotient (5.48 ± 2.48 
vs. 6.36 ± 3.47; p = 0.350, n = 52), and IgG index (0.49 ± 0.09 
vs. 0.50 ±  0.16; p =  0.838, n =  53). In addition, patients with 
(n = 12) and without (n = 51) clear-cut alterations in the CSF 
were compared. Alterations in the CSF were detected significantly 
more often in male patients (8 of 12 were male; chi-square = 4.5, 
p = 0.034). The cMRI pathologies (chi-square = 0.01, p = 0.904) 
and the rate of EEG alterations (chi-square = 0.33, p = 0.564) was 
not statistically different between the two groups.
DiscUssiOn
As the main findings of this open, retrospective, uncontrolled 
study, we observed pathological alterations in the CSF in 19% of 
patients with BD. The CSF findings did not differ between manic 
and depressive patients in a statistically significant way. Male 
patients showed a higher rate of clear-cut alterations in the CSF.
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limitations
The first main limitation of this retrospective study is the missing 
control group. Therefore, the current study’s findings could not 
be compared to those of healthy controls. However, due to the 
potential side effects of lumbar punctures (e.g., headache, vomit-
ing, nerve damage, and infection), at the current stage of research, 
it was not ethically justifiable to puncture healthy controls. 
Therefore, we compared our findings with well-established refer-
ence values based on extensive work by Reiber et al.2 Furthermore, 
we compared our results to those for other psychiatric patient 
cohorts, which were analyzed with the same methods in the same 
laboratory (19, 20). In cases of increased IgG indices, OCBs were 
not measured earlier in our laboratory. However, the findings 
of increased IgG indices are susceptible [e.g., due to increased 
albumin quotients; (22)]. To avoid the production of unreliable 
results, we also looked at the albumin quotient and the IgG frac-
tion in the Reibergrams. Further studies should always analyze 
OCBs. The second main limitation of this study is due to its open 
and retrospective nature. At the University Clinic of Freiburg, 
for many years, CSF analyses had been offered and generally 
was performed only in selected patients with clinical signs or 
constellations suggestive of organic features. This of course leads 
to a probable selection bias of the sample. Therefore, the findings 
cannot be generalized to the overall group of bipolar patients 
presenting to a psychiatric clinic. However, to avoid an overinclu-
sion of patients with suggestive organic features in this cohort, all 
patients with comorbid disorders associated with alterations in the 
CSF were excluded (see Table 1). Thus, only patients without pre-
existing organic causes for secondary organic bipolar syndromes 
were analyzed, and thus, from a clinical perspective, a cohort of 
patients with apparently endogenic primary BD was created. Due 
to the retrospective approach, we were not able to analyze the role 
of infrequent possible extracranial-influencing factors, such as 
spinal canal stenosis. Because of the retrospective character and 
the limited number of patients, other potentially relevant factors 
like medication have not been adequately addressed in this study. 
This also led to an incomplete dataset (e.g., autoantibodies were 
not measured in all patients). Thus, bigger prospective studies 
should be performed with predefined measurement protocols, 
including analyses of medicated and unmedicated BD patients. 
In spite of these shortcomings, this study is clinically important 
because it is, to the authors’ knowledge, the first study that focused 
primarily on complete routine CSF findings in combination with 
cMRI and EEG findings. Previous studies mostly focused on the 
role of BBB dysfunction (15, 16).
results in the context of Previous studies
The results are in line with those of previous studies that described 
increased total protein concentrations in some patients with BD 
(15, 16). We also found CSF alterations predominantly in male 
patients (16). In comparison to patients with psychosis, the rate 
of alterations in the CSF was lower. In patients with psychosis, 
increased cell counts were found in 3.4% (vs. 1.6% in BD), an 
elevated albumin quotient in 21.8% (vs. 12.9% in BD), and 
2 www.horeiber.de/liquor.html.
augmented intrathecal immunoglobulin synthesis in 7.2% [vs. 
potentially 4.8% in BD; (19)]. These differences support the idea 
that bipolar syndromes occur only in a small subgroup due to 
secondary inflammatory processes. This observation relates well 
to the clinical presentation of intermittent full remission without 
causal (e.g., immunomodulatory and anti-infectious) therapy. 
One might speculate that secondary forms due to inflammatory 
or neurodegenerative processes lead to chronic courses of the dis-
ease if the forms are not treated causally. However, our findings of 
clear-cut alterations in the CSF in 19% of patients are compatible 
with mild encephalitis (12) and immunological encephalopathies 
(4) in defined subgroups of patients with BD. These patients often 
show unspecific alterations in the CSF. Patients with Hashimoto’s 
encephalopathy (HE) showed mild lymphocytic pleocytosis 
in 25% of cases, increased protein levels in 85%, and OCBs in 
8.3% (24). Patients with anti-N-methyl-d-aspartic acid receptor 
(NMDAR) encephalitis showed initially abnormal findings in 
80% of the cases. WBC counts were often mildly increased, and 
in 60% of patients, CSF-specific OCBs were detected (25). EEG 
alterations were found in 95% of patients with HE and nearly 
all patients with anti-NMDA encephalitis (4). In the cMRI of 
patients with HE, often normal or non-specific white matter 
lesions were detected (in 74%), and about 20% of the patients 
had diffuse increased signaling on T2-weight images (24). In 
50% of patients with anti-NMDA-R encephalitis, the cMRI was 
unremarkable, and in the other half of the patients, T2 or FLAIR 
signal hyperintensity was found in the hippocampi, and in the 
cerebellar or cerebral cortex, frontobasal and insular regions, 
basal ganglia, and brainstem (25).
alterations in the csF in the  
current study and in general
Increased WBC counts, intrathecal immunoglobulin synthesis, 
and increased albumin quotients are unspecific but notice-
able CSF findings (22). Increased WBC counts and intrathecal 
immunoglobulin synthesis are associated with acute and chronic 
inflammatory processes. In contrast, increased albumin quotients 
are unspecific findings. They can be caused by a broad spectrum 
of inflammatory CNS processes but also by systemic disorders, 
such as alcohol or diabetes-induced polyneuropathy, as well as by 
spinal canal stenosis (14).
WBC Count
Slightly increased WBC counts (5–30  cells/μl) can be due to 
stimulus pleocytosis (e.g., epileptic seizure) and are often found 
in immunological encephalopathies (4, 14). WBC counts above 
30/μl are increased significantly and are distinct signs of infec-
tious neuroinflammation [i.e., neuroborreliosis, neurosyphilis, 
meningitis, brain abscess, etc. (14)]. One patient in our cohort 
(Patient 1, Table  4) showed an isolated mild increase in WBC 
count (6  cells/μl) without other specific alterations in the CSF 
and no evidence of infectious agents. cMRI showed an over-the-
years unchanged left cerebellar cavernoma with an associated 
developmental venous anomaly without hemorrhage. Moreover, 
cMRI depicted mild supratentorial atrophy and unspecific white 
matter lesions. No epileptic seizures were reported. One might 
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speculate that the combination of mild pleocytosis in combina-
tion with cerebral atrophy, white matter lesions, and clinically 
evident cognitive deficits might be associated with mild chronic 
immunological encephalopathy. Alternatively, the findings could 
be unspecific, especially because no increased intrathecal immu-
noglobulin synthesis was detected.
Intrathecal Immunoglobulin Synthesis
One female patient (Patient 2, Table 4), with a normal WBC 
count, intact BBB function, and normal IgG index, showed 
weak CSF-specific OCBs; serological analyses showed increased 
thyroglobulin antibodies. The cMRI showed alterations around 
the right lateral ventricle with mild gliosis and reduced white 
matter volume. The EEG showed generalized slowing; the 
test for attentional performance (TAP) showed deficits in all 
domains. These findings are compatible with multiple sclerosis 
(MS) or HE. However, a relapsing disease course suggestive 
for MS was not reported by the patient. Additionally, the cMRI 
Swanton criteria for dissemination in time and space were 
not fulfilled and the MRZ reaction, a polyspecific, intrathe-
cal humoral immune response against neurotropic agents 
(measles, rubella, and varicella zoster virus), which is possibly 
the most specific available CSF marker for MS (26), was also 
negative. Therefore, we were not able to diagnose MS or an 
early stage of this disease although previous studies showed an 
association between BD and MS (27, 28). The OCBs could also 
be an “immunological scar” after a previous CNS infection; 
however, a history of previous CNS infections was negative. 
HE could also be a possible reason. HE can be diagnosed by 
exclusion if the patient (1) suffers from encephalopathy with 
psychiatric symptoms (hallucinations, etc.), seizures, myo-
clonus, etc.; (2) has subclinical or mildly overt thyroid disease; 
(3) shows maximal non-specific cMRI alterations; (4) shows 
the presence of serum thyroid antibodies; and (5) shows the 
absence of autoantibodies against intracellular and cell-surface 
antigens (29). However, no steroid treatment was performed 
in this patient, which might have supported this differential 
diagnosis (8). Patient 3, with an increased IgG index, normal 
albumin quotient, and significantly increased IgG fraction in 
the Reibergram (~50%) also showed atrophic alterations in 
the context of hypothyroidism. Clarification for Hashimoto’s 
thyroiditis was not performed, and perhaps, again, HE could 
be one possible reason. This patient also suffered from psoriasis 
vulgaris; therefore, an autoinflammatory predisposition seems 
to be plausible. Such associations with autoimmune diseases 
have been described previously (30). One might speculate 
that the bipolar symptoms and the thyroid and skin disease 
are different signs of immune dysregulation in this patient. In 
line with this, a previous case report described a patient with 
BD and psoriasis. During the depressive episodes, the skin 
lesions worsened, and during the manic episodes, the pso-
riasis improved without specific treatment (31). The increased 
IgG index in Patient 4 is associated with a normal albumin 
quotient and a borderline IgG fraction in the Reibergram 
(~10%). Alterations in this patient are most likely due to 
previous clinically inapparent syphilis infection of the CNS 
following the previous syphilis infection in the primary stage 
that was successfully treated with antibiotics. Unfortunately, a 
diagnostic workup for neurosyphilis (including calculation of 
the antibody index) and measuring of OCBs – which would 
have provided more clarity – were not available for this patient. 
Patients with depressive (in 5%) and manic syndromes (in 
3%) have earlier been described as rare but possible clinical 
presentations of neurosyphilis (32, 33).
Albumin Quotient
The age-dependent serum and CSF albumin quotient is the 
reference standard for measuring BBB function (22). In a previ-
ous study we detected increased albumin quotients in 21.8% of 
patients with psychosis (19). In the present bipolar cohort the 
rate of patients with increased albumin quotients was 12.9% and, 
therefore, lower than in patients with psychosis but higher than 
in patients with other neurological disorders, like optic neuritis, 
where BBB dysfunction was only found in 3.8% (19, 34). Increased 
albumin quotients are unspecific but can also be found in most 
types of immunological encephalopathies. Some authors suggest 
that intermittent BBB dysfunction is required for the develop-
ment of autoantibody-associated immunological encephalopa-
thy. Following this line of thought, common autoantibodies in 
the serum [e.g., anti-NMDAR-antibodies (35, 36)] can reach the 
brain only in patients with BBB dysfunction (35).
The role of csF analyses in  
Patients with Bipolar Disorder
Currently, CSF analyses are not generally recommended in 
patients with bipolar syndromes according to present guidelines 
(e.g., Nice guidelines3; German S3-Praxisleitlinie4). To avoid 
overlooking clinically potentially important immunological and 
infectious encephalopathies in a previous paper, the authors 
suggested to consider CSF analyses for patients with (1) 
laboratory- (e.g., hyponatremia and thyroid autoantibodies) and 
instrument-based alterations (e.g., EEG and cMRI alterations), 
(2) (sub)acute beginning of the symptoms, (3) an association 
between the beginning of symptoms and a feverish condition 
or vegetative derailment, (4) atypical clinical presentation, and 
(5) additional neurological symptoms [e.g., epileptic seizures, 
myoclonic jerks, other movement disorders (4)].
cOnclUsiOn
This open uncontrolled study revealed evidence for rare, but rel-
evant, alterations in the CSF in patients with bipolar syndromes. 
Alterations in the CSF in patients with BD are less frequent than in 
patients with psychosis. In daily clinical practice, findings in MRI 
and EEG basic diagnostics, or an atypical clinical presentation 
(e.g., with neurological symptoms), should also lead the clinician 
to consider an underlying encephalopathic pathomechanism. 
Future studies should analyze CSF findings in a prospective, 
controlled setting and correct for frequent influential factors 
(e.g., alcohol use, medication, diabetes, age, and gender). The 
3 http://www.nice.org.uk.
4 www.dgppn.de.
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detection of patient subgroups with infectious or immunological 
encephalitis could open up new causal treatment options.
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